Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02424110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT02424110
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02424110. Randomized; double masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- argon beam coagulator ablation
- Intervention (Procedure)
- bipolar radiofrequency ablation
- Intervention (Device)
- argon beam coagulator (American,Valleylab)
- Intervention (Device)
- bipolar radiofrequency (AtricuteTM)
- Lead sponsor
- Xinqiao Hospital of Chongqing
Record details
- Record id
cardio:ct-nct02424110- Content hash
b5c9146812c9c5a2aba16759c4230029582ce956a212191170f908fc7c132093